cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Cullinan Oncology Inc
1 own
1 watching
Current Price
$11.77
$-0.14
(-1.18%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
538.4M
52-Week High
52-Week High
15.89
52-Week Low
52-Week Low
7.3
Average Volume
Average Volume
0.35M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization538.4M
icon52-Week High15.89
icon52-Week Low7.3
iconAverage Volume0.35M
iconDividend Yield--
iconP/E Ratio--
What does the Cullinan Oncology Inc do?
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company s lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with non-small cell lung cancer. Its preclinical products include CLN-049, a humanized bispecific antibody for the treatment of acute myeloid leukemia; CLN-619, a monoclonal antibody for the treatment of solid tumors; CLN-617, a fusion protein for the treatment of solid tumors; CLN-978, a T cell engaging antibody for B-cell malignancies; Opal, a bispecific fusion protein to block the PD-1 axis, and to activate the 4-IBB/CD137 pathway on T cells in tumors; and Jade, a cell therapy to target a novel senescence and cancer-related protein. The company has collaboration agreements with Cullinan Pearl Corp. to develop, manufacture, and commercialize CLN-081 and products containing CLN-081; and Adimab, LLC to discover and/or optimize antibodies. Cullinan Oncology, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Cullinan Oncology Inc make?
News & Events about Cullinan Oncology Inc.
Globe Newswire
12days ago
CAMBRIDGE, Mass., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc.(Nasdaq: CGEM), a biopharmaceutical company focused on modality-agnostic targeted oncology therapies, today announcedthe U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for ...
Globe Newswire
6 months ago
CAMBRIDGE, Mass., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (Cullinan Oncology) a biopharmaceutical company focused on developing a diversified pipeline of targeted therapies for patients with cancer, today announced that its Chief Financial Officer, Jeff Trigilio, ...
Globe Newswire
8 months ago
Updated data from Phase 1/2a study show median duration of response greater than 21 months and median progression-free survival of 12 months at 100 mg BID dose Confirmed overall response rate of 41% at 100 mg BID dose Continued favorable safety and tolerability profile observed in heavily pre-...
Globe Newswire
8 months ago
Meeting to highlight updated data from the Phase 1/2a study of CLN-081 CAMBRIDGE, Mass., May 26, 2022 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM) (Cullinan) a biopharmaceutical company focused on developing a diversified pipeline of targeted therapies for patients with cancer, today ...
Globe Newswire
8 months ago
Taiho obtains exclusive global rights to CLN-081/TAS6417 outside the U.S.; in the U.S., Taiho and Cullinan Oncology to jointly develop and co-commercialize CLN-081/TAS6417 Cullinan Oncology will receive an upfront cash payment of $275 million, with potential to receive up to an additional $130 ...
Frequently Asked Questions
Frequently Asked Questions
What is Cullinan Oncology Inc share price today?
plus_minus_icon
Can Indians buy Cullinan Oncology Inc shares?
plus_minus_icon
How can I buy Cullinan Oncology Inc shares from India?
plus_minus_icon
Can Fractional shares of Cullinan Oncology Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Cullinan Oncology Inc stocks?
plus_minus_icon
What is today’s traded volume of Cullinan Oncology Inc?
plus_minus_icon
What is today’s market capitalisation of Cullinan Oncology Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Cullinan Oncology Inc?
plus_minus_icon
What percentage is Cullinan Oncology Inc down from its 52-Week High?
plus_minus_icon
What percentage is Cullinan Oncology Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$11.77
$-0.14
(-1.18%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00